Katherine F. Warfel

Katherine F. Warfel

Auto-generated profile, based on publicly available information

Katherine F. Warfel

Department of Chemical and Biological Engineering, Northwestern University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2024 in Chemical Reviews
Verified
Journal Article
Open access
AHAndrew C. Hunt
Andrew C. Hunt
BRBlake J. Rasor
Blake J. Rasor
KSKosuke Seki
Kosuke Seki
HEHolly M. Ekas
Holly M. Ekas
KWKatherine F. Warfel
Katherine F. Warfel
MJMichael C. Jewett
Michael C. Jewett
Cell-free gene expression (CFE) systems empower synthetic biologists to build biological molecules and processes outside of living intact cells. The foundational principle is that precise, complex biomolecular transformations can be conducted in purified enzyme or crude cell lysate systems. This concept circumvents mechanisms that have evolved to facilitate species survival, bypasses limitations on molecular transport across the cell wall, and provides a significant departure from traditional, cell-based processes that rely on microscopic cellular "reactors." In addition, cell-free systems are inherently distributable through freeze-drying, which allows simple distribution before rehydration at the point-of-use. Furthermore, as cell-free systems are nonliving, they provide built-in safeguards for biocontainment without the constraints attendant on genetically modified organisms. These features have led to a significant increase in the development and use of CFE systems over the past two decades. Here, we discuss recent advances in CFE systems and highlight how they are transforming efforts to build cells, control genetic networks, and manufacture biobased products.

5 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
JSJessica C. Stark
Jessica C. Stark
TJThapakorn Jaroentomeechai
Thapakorn Jaroentomeechai
TMTyler Moeller
Tyler Moeller
JHJasmine M. Hershewe
Jasmine M. Hershewe
KWKatherine F. Warfel
Katherine F. Warfel
MJMichael C. Jewett
Michael C. Jewett
Conjugate vaccines are among the most effective methods for preventing bacterial infections. However, existing manufacturing approaches limit access to conjugate vaccines due to centralized production and cold chain distribution requirements. To address these limitations, we developed a modular technology for in vitro conjugate vaccine expression (iVAX) in portable, freeze-dried lysates from detoxified, nonpathogenic Escherichia coli. Upon rehydration, iVAX reactions synthesize clinically relevant doses of conjugate vaccines against diverse bacterial pathogens in 1 hour. We show that iVAX-synthesized vaccines against Francisella tularensis subsp. tularensis (type A) strain Schu S4 protected mice from lethal intranasal F. tularensis challenge. The iVAX platform promises to accelerate development of new conjugate vaccines with increased access through refrigeration-independent distribution and portable production.

22 December 2022 in ACS Synthetic Biology
Verified
Journal Article
Open access
KWKatherine F. Warfel
Katherine F. Warfel
AWAsher Williams
Asher Williams
DWDerek A. Wong
Derek A. Wong
SSSarah E. Sobol
Sarah E. Sobol
PDPrimit Desai
Primit Desai
MJMichael C. Jewett
Michael C. Jewett

11 June 2020 in ACS Synthetic Biology
Verified
Journal Article
Open access
WKWeston Kightlinger
Weston Kightlinger
KWKatherine F. Warfel
Katherine F. Warfel
Matthew Peter DeLisaMatthew Peter DeLisa
Matthew Peter DeLisa
MJMichael C. Jewett
Michael C. Jewett
Protein glycosylation, the attachment of sugars to amino acid side chains, can endow proteins with a wide variety of properties of great interest to the engineering biology community. However, natural glycosylation systems are limited in the diversity of glycoproteins they can synthesize, the scale at which they can be harnessed for biotechnology, and the homogeneity of glycoprotein structures they can produce. Here we provide an overview of the emerging field of synthetic glycobiology, the application of synthetic biology tools and design principles to better understand and engineer glycosylation. Specifically, we focus on how the biosynthetic and analytical tools of synthetic biology have been used to redesign glycosylation systems to obtain defined glycosylation structures on proteins for diverse applications in medicine, materials, and diagnostics. We review the key biological parts available to synthetic biologists interested in engineering glycoproteins to solve compelling problems in glycoscience, describe recent efforts to construct synthetic glycoprotein synthesis systems, and outline exemplary applications as well as new opportunities in this emerging space.

22 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJasmine M. Hershewe
Jasmine M. Hershewe
KWKatherine F. Warfel
Katherine F. Warfel
SIShaelyn M. Iyer
Shaelyn M. Iyer
JPJustin A. Peruzzi
Justin A. Peruzzi
CSClaretta J. Sullivan
Claretta J. Sullivan
MJMichael C. Jewett
Michael C. Jewett
Cell-free gene expression (CFE) systems from crude cellular extracts have attracted much attention for biomanufacturing and synthetic biology. However, activating membrane-dependent functionality of cell-derived vesicles in bacterial CFE systems has been limited. Here, we address this limitation by characterizing native membrane vesicles in Escherichia coli-based CFE extracts and describing methods to enrich vesicles with heterologous, membrane-bound machinery. As a model, we focus on bacterial glycoengineering. We first use multiple, orthogonal techniques to characterize vesicles and show how extract processing methods can be used to increase concentrations of membrane vesicles in CFE systems. Then, we show that extracts enriched in vesicle number also display enhanced concentrations of heterologous membrane protein cargo. Finally, we apply our methods to enrich membrane-bound oligosaccharyltransferases and lipid-linked oligosaccharides for improving cell-free N-linked and O-linked glycoprotein synthesis. We anticipate that these methods will facilitate on-demand glycoprotein production and enable new CFE systems with membrane-associated activities.

16 June 2023 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JSJessica C. Stark
Jessica C. Stark
TJThapakorn Jaroentomeechai
Thapakorn Jaroentomeechai
KWKatherine F. Warfel
Katherine F. Warfel
JHJasmine M. Hershewe
Jasmine M. Hershewe
Matthew Peter DeLisaMatthew Peter DeLisa
Matthew Peter DeLisa
MJMichael C. Jewett
Michael C. Jewett